Multi Medika Internasional Stock Fundamentals
| MMIX Stock | 99.00 9.00 10.00% |
Multi Medika Internasional fundamentals help investors to digest information that contributes to Multi Medika's financial success or failures. It also enables traders to predict the movement of Multi Stock. The fundamental analysis module provides a way to measure Multi Medika's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Multi Medika stock.
Multi |
Multi Medika Internasional Company Return On Asset Analysis
Multi Medika's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Multi Medika Return On Asset | 0.37 |
Most of Multi Medika's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Multi Medika Internasional is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Multi Medika Internasional has a Return On Asset of 0.3714. This is 104.24% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on asset for all Indonesia stocks is notably lower than that of the firm.
Multi Medika Interna Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Multi Medika's current stock value. Our valuation model uses many indicators to compare Multi Medika value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Multi Medika competition to find correlations between indicators driving Multi Medika's intrinsic value. More Info.Multi Medika Internasional is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Multi Medika Internasional is roughly 4.86 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Multi Medika's earnings, one of the primary drivers of an investment's value.Multi Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Multi Medika's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Multi Medika could also be used in its relative valuation, which is a method of valuing Multi Medika by comparing valuation metrics of similar companies.Multi Medika is rated below average in return on asset category among its peers.
Multi Fundamentals
| Return On Equity | 1.81 | |||
| Return On Asset | 0.37 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.18 % | |||
| Shares Owned By Insiders | 7.00 % | |||
| Price To Sales | 3.41 X | |||
| Revenue | 181.84 B | |||
| Gross Profit | 67.57 B | |||
| EBITDA | 33.57 B | |||
| Book Value Per Share | 27.86 X | |||
| Number Of Employees | 63 | |||
| Market Capitalization | 1.27 T |
About Multi Medika Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Multi Medika Internasional's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Multi Medika using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Multi Medika Internasional based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Multi Stock
Multi Medika financial ratios help investors to determine whether Multi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Multi with respect to the benefits of owning Multi Medika security.